Author:
Shabbir Arafat,Kojadinovic Arsenije,Shafiq Tabinda,Mundi Prabhjot S.
Reference83 articles.
1. Immunotherapy in non-small cell lung cancer harbouring driver mutations;Addeo;Cancer Treat. Rev.,2021
2. GDNF family neurotrophic factor signaling: four masters, one servant?;Airaksinen;Mol. Cell Neurosci.,1999
3. ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research;Belli;Ann. Oncol.,2021
4. In vitro and in vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancer;Bentzien;Thyroid,2013
5. Efficacy of immune checkpoint inhibitor therapy in patients with RET fusion-positive non-small-cell lung cancer;Bhandari;Immunotherapy,2021
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献